2025-08-28 22:56:40
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
Godavari Drugs Q3FY22 net profit climbs to Rs. 1.33 crore
Posted On : 2022-02-14 18:22:35( TIMEZONE : IST )
GODAVARI DRUGS LTD. has reported Standalone financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 33.8104 crores during the period ended December 31, 2021 as compared to Rs. 38.7572 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 1.3322 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 1.2213 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 1.77 for the period ended December 31, 2021 as compared to Rs. 1.62 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 33.8104 crs | ₹38.7572 crs |  -12.76% |
| Net Profit | ₹1.3322 crs | ₹1.2213 crs |  9.08% |
| EPS | ₹1.77 | ₹1.62 | 9.26% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 33.8104 crores during the period ended December 31, 2021 as compared to Rs.33.1810 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.1.3322 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.1.0026 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.1.77 for the period ended December 31, 2021 as compared to Rs.1.33 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 33.8104 crs | ₹33.1810 crs | 1.90% |
| Net Profit | ₹1.3322 crs | ₹1.0026 crs | 32.87% |
| EPS | ₹1.77 | ₹1.33 | 33.08% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.116.9864 crores during the 9 Months period ended December 31, 2021 as compared to Rs.90.0078 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.3.9778 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.2.8417 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.5.28 for the 9 Months period ended December 31, 2021 as compared to Rs.3.77 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹116.9864 crs | ₹90.0078 crs | 29.97% |
| Net Profit | ₹3.9778 crs | ₹2.8417 crs | 39.98% |
| EPS | ₹5.28 | ₹3.77 | 40.05% |
Shares of GODAVARI DRUGS LTD. was last trading in BSE at Rs. 60.30 as compared to the previous close of Rs. 62.45. The total number of shares traded during the day was 7072 in over 98 trades.
The stock hit an intraday high of Rs. 62.90 and intraday low of 58.10. The net turnover during the day was Rs. 427781.00.
